Ulf has more than 20 years of experience from pharmaceutical companies such as Novo Nordisk, Astra Zeneca and ALK AS.
He has spent the last 13 years in the biotechnology industry as EVP Marketing & Innovation at the Nasdaq-listed company Enzymatica, of which he is also a co-founder.
He has ongoing board assignments in Enzymatica Care AB and previous assignments in listed Idogen AB. He is also the owner of a financial company, MedZyme Invest AB.
Education: MSc in Business Administration and certified pharmaceutical consultant, courses in strategy, leadership, governance and due diligence
Other appointments: Enzymatica AB (EVP Marketing & Innovation), Enzymatica Care AB (member)
Holdings: No shares